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Background: Correct speciﬁcation of cell lineages and establishing angiogenic privilege within the developing cornea are essen-
tial for normal vision but the mechanisms controlling these processes are poorly understood. Results: We show that the homeo-
domain transcription factor PItX2 is expressed in mesenchymal cells of the developing and mature cornea and use a temporal
gene knockout approach to demonstrate that PITX2 is required for corneal morphogenesis and the speciﬁcation of cell fates
within the surface ectoderm and mesenchymal primordia. PITX2 is also required to establish angiogenic privilege in the develop-
ing cornea. Further, the expression of Dkk2 and suppression of canonical Wnt signaling activity levels are key mechanisms by
which PITX2 speciﬁes ocular surface ectoderm as cornea. In contrast, specifying the underlying mesenchyme to corneal fates and
establishing angiogenic privilege in the cornea are less sensitive to DKK2 activity. Finally, the cellular expression patterns of
FOXC2, PITX1, and BARX2 in Pitx2 and Dkk2 mutants suggest that these transcription factors may be involved in specifying cell
fate and establishing angiogenic privilege within the corneal mesenchyme. However, they are unlikely to play a role in specifying
cell fate within the corneal ectoderm. Conclusions: Together, these data provide important insights into the mechanisms regulat-
ing cornea development. Developmental Dynamics 243:1391–1400, 2014. VC 2014 Wiley Periodicals, Inc.
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Introduction
The cornea provides important properties that are required for
normal visual acuity, including transparency, refraction, and pro-
tection of inner components of the eye from external environ-
mental factors. The mature cornea consists of three cellular
layers, a 6–7-cell-thick corneal epithelium that comprises the
outer surface, a monolayer endothelium that forms the inner sur-
face, and a stroma layer that lies between the epithelium and the
endothelium and consists of a highly ordered lamellar arrange-
ment of keratocytes and specialized collagen bundles (Chow and
Lang, 2001; Cvekl and Tamm, 2004). The corneal epithelium
arises from surface ectoderm during development, where as the
endothelium and stroma are formed from mesenchyme that,
depending upon the species, largely or totally derives from neural
crest (Gage et al., 2005; Le Douarin, 1980; Le Lievre and Le
Douarin, 1975). Understanding how intrinsic and extrinsic factors
mesh to control cell fate decisions and gene expression in each
cellular layer during development is likely to enhance the devel-
opment of new and improved strategies for treating corneal
diseases.
Normal vision also requires the complete absence of blood and
lymphatic vessels from the cornea, a property referred to as
angiogenic privilege. Loss of angiogenic privilege as a conse-
quence of developmental abnormalities or postnatal insult results
in corneal neovascularization, a sight threatening condition.
Therefore, a detailed understanding of how angiogenic privilege
is initially established during development and subsequently pre-
served in the mature cornea is important for expanding our
knowledge of corneal development and identifying new, more
effective therapies.
The onset of corneal development is morphologically apparent
when neural crest mesenchyme begins to migrate between the
newly formed lens vesicle and the overlying surface ectoderm
(Cvekl and Tamm, 2004). The endothelium is the first differenti-
ated corneal layer to differentiate, and it arises from mesenchy-
mal cells that contact with the anterior lens epithelia.
Subsequently, mesenchymal cells between the newly formed
endothelium and the overlying ocular surface ectoderm become
compact and adopt an ordered and lamellar arrangement to form
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the corneal stroma. Blood vessels never appear in the developing
cornea, indicating that angiogenic privilege is established early
during corneal morphogenesis. Cell signaling from cells of the
anterior lens vesicle and the distal rim of the optic cup acts
directly upon the mesenchyme early in corneal development to
induce expression of transcription factor genes that are broadly
required for normal anterior segment development, including
Foxc1 and Pitx2 (Matt et al., 2005; Molotkov et al., 2006). Of
these, only Foxc1 has been established as a gene that specifies
cell fates and angiogenic privilege in the developing cornea (Kid-
son et al., 1999; Seo et al., 2012). Concurrent with development
of the endothelium and stroma, the overlying ocular surface ecto-
derm is specified as cornea and signaling from the underlying
mesenchymal cells is for this process (Pearton et al., 2005).
The ocular surface ectoderm and underlying mesenchyme also
give rise to the conjunctiva, which lies between the cornea and
the posterior margin of the eyelid. The cellular components of the
conjunctiva are highly distinct from those of the cornea, and the
conjunctival mesenchyme is highly vascularized. The mecha-
nisms underlying segregation of the multipotent ocular surface
ectoderm and mesenchyme into corneal versus conjunctival fates
during development are unknown.
Given its fundamental role in governing development of early
anterior segment tissues (Evans and Gage, 2005a; Gage et al.,
1999), we hypothesize that Pitx2 is also required for specifying cell
lineages and establishing angiogenic privilege within the develop-
ing cornea. Pitx2 encodes a paired-like homeodomain transcrip-
tion factor that is important in both development and disease.
Heterozygous mutations in human PITX2 are one genetic cause of
Axenfeld-Rieger Syndrome (ARS), which features dysgenesis of
anterior segment structures within the eye and a high risk for glau-
coma (Semina et al., 1996). ARS patients with PITX2 mutations, as
well as Pitx2 heterozygous mice, exhibit decreased central corneal
thickness (CCT), consistent with a potential role for PITX2 in cor-
neal development (Asai-Coakwell et al., 2006). Global or neural
crest-specific ablation of Pitx2 results in the arrest of anterior seg-
ment development at a stage prior to the initiation of corneal
development, thereby making these models unsuitable for assess-
ing gene function in the latter process (Evans and Gage, 2005a;
Gage et al., 1999). To circumvent this blockade, we employed a
temporal gene knockout approach in the current study. We dem-
onstrate that PITX2 is required for specifying lineages and estab-
lishing angiogenic privilege in the developing cornea. In the
absence of PITX2, the surface ectoderm and mesenchyme acquire
gene expression patterns more consistent with conjunctival fates,
Dkk2 expression is not maintained within the corneal mesen-
chyme, and canonical Wnt signaling activity becomes elevated
within the developing cornea. Maintenance of normal canonical
Wnt signaling through its downstream target Dkk2 appears to be
an essential mechanism by which PITX2 controls normal specifica-
tion of the corneal epithelium.
Results
Pitx2 Is Required for Normal Histogenesis and
Establishing Angiogenic Privilege in the Developing
Cornea
As shown previously, central corneal thickness is reduced in mice
and humans harboring a 50% reduction in PITX2, suggesting a
potential direct role in cornea development (Asai-Coakwell et al.,
2006). However, this result could also arise from an indirect effect
such as elevated intraocular pressure leading to corneal thinning.
Therefore, we analyzed protein expression in developing and
mature corneas in the mouse to determine whether there was the
potential for PITX2 to have a direct effect on corneal develop-
ment. We found that PITX2 protein is uniformly expressed in the
mesenchymal layer of the developing cornea, as well as in the
stroma and endothelium layers in the mature cornea, consistent
with a potential role for PITX2 in regulating corneal development
(Fig. 1).
Anterior segment development is arrested in global and neural
crest-specific Pitx2 knockout mice prior to initiation of corneal
development (Evans and Gage, 2005b; Gage et al., 1999). There-
fore, we employed a temporal knockout strategy that allowed us
to rescue the initial arrest in anterior segment development but
still ablate Pitx2 at the beginning of corneal development (Zacha-
rias et al., 2011). Briefly, we crossed mice carrying our condi-
tional Pitx2flox allele together with mice carrying the UBC-
CreERt2 transgene, which ubiquitously expresses a Cre fusion
protein that is inactive in the absence of tamoxifen (Gruber et al.,
2007; Ruzankina et al., 2007). Timed pregnant females carrying
prospective mutants (UBC-CreERt2:Pitx2flox/null) and controls
(Pitx2flox/null) were injected with tamoxifen at e10.5 to activate
the CreERT2 fusion protein and ablate Pitx2 in the prospective
mutant (Pitx2-tko) mice at the beginning of corneal morphogene-
sis. The Pitx2 gene was deleted and PITX2 protein is degraded in
Pitx2-tko embryos within 24 hr, making this system highly
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Fig. 1. PITX2 expression in developing and mature corneas. PITX2 immunostaining on e14.5 (A) and 6-week old (B) cornea. e, corneal endothe-
lium; m, corneal mesenchyme; s, corneal stroma.
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efficient (Fig. 2B). PITX2-positive cells do not reemerge in older
embryos (Fig. 2C–H).
We first used a histological approach to investigate the conse-
quences of ablating Pitx2 (Fig. 3). Mesenchymal cells in control
littermates begin to populate the space between the developing
lens and overlying surface ectoderm by e11.5, and their number
is markedly increased by e12.5 (Fig. 3A,B). By e14.5, a monolayer
of endothelium is present on the inner surface of the mesenchy-
mal layer and an obvious anterior chamber has formed (Fig. 3C).
Beginning at e14.5 and continuing through e16.5, cells within
the emerging stroma cells adopt an increasingly organized and
laminar appearance within the mesenchyme located between the
endothelium and the overlying surface ectoderm. By e16.5, all
three layers of the cornea are well delineated (Fig. 3D). By e11.5,
corneas in Pitx2-tko are indistinguishable from controls. How-
ever, by e12.5 the mesenchymal component in mutant embryos is
thickened relative to corneas of control littermates (Fig. 3E,F). At
14.5, the endothelium is absent from Pitx2-tko corneas, and the
putative stromal cell layer is significantly thicker and less well
organized than in controls. In addition, multiple abnormal histo-
logical layers are often visible within the putative stroma (Fig.
3G). The disorganization of the corneal tissues persists through
e16.5 and the lack of an anterior chamber confirms the absence
of a functional endothelium (Fig. 3H and data not shown). The
ectodermal layer of Pitx2-tko corneas is modestly thickened rela-
tive to control corneas. Collectively, these data establish that
PITX2 is required for correct morphogenesis within each of three
layers of the developing cornea.
We also noted the presence of blood vessels in corneas of
Pitx2-tko mice. To more readily visualize this, Pitx2-tko and con-
trol eyes were immunostained for presence of the blood vessel
endothelial cell marker, CD31. As expected, the avascular control
corneas are devoid of CD31 staining (Fig. 4A). In contrast, by late
gestation Pitx2-tko corneas are heavily invested with CD31þ
blood vessels by late gestation (Fig. 4C). Because lymphangiogen-
esis frequently parallels angiogenesis, we also tested control and
Pitx2-tko eyes for the presence of lymphatic vessels. By late in
gestation, LYVE1þ lymphatic vessels are absent from control cor-
neas but readily detectable in Pitx2-tko corneas by late in gesta-
tion (Fig. 4B,D). These data confirm that PITX2 function is
required to establish angiogenic privilege.
Gene Expression in Pitx2-tko Corneal Mesenchyme
Resembles That of Conjunctival Mesenchyme
We next characterized whether the morphological changes
observed in mutant corneas during the first several days follow-
ing Pitx2 ablation were accompanied by alterations in the spatial
or temporal patterns of gene expression. We observed that in
control embryos at e12.5, immunostaining to detect the forkhead
transcription factor FOXC2 distinguishes the corneal mesen-
chyme, where it is not expressed, and the periocular mesenchyme
of the future conjunctiva and posterior of the optic cup, where it
is expressed (Fig. 5A). In contrast to control embryos, in Pitx2-
tko littermates, FOXC2 is uniformly high throughout the periocu-
lar mesenchyme, including the presumptive corneal mesenchyme
(Fig. 5E). Similarly, we immunostained sections for the homeodo-
main transcription factor PITX1. In control mice at e13.5, PITX1
is highly expressed in the conjunctival mesenchyme but only
minimally in the corneal mesenchyme of control mice at e13.5
(Fig. 5B). In Pitx2-tko mice, PITX1 expression is uniformly high
in both the conjunctival and corneal mesenchyme (Fig. 5F). In
situ hybridization was then used to detect expression of the gene
for the bHLH transcription factor Twist1. In control embryos at
e14.5, Twist1 is expressed in the corneal mesenchyme but not in
the conjunctival mesenchyme (Fig. 5C, Thut et al., 2001). In
Pitx2-tko siblings, Twist1 expression is not detectable in either
the corneal or conjunctival mesenchyme (Fig. 5G). Finally, in situ
hybridization was used to examine the expression of Keratocan,
which has been identified as a gene whose expression pattern is
specific to cells in the corneal stroma during late development
and continuing in adults (Liu et al., 1998). Here, however, we
found a more complex expression pattern. In control embryos at
e14.5, high levels of Keratocan are expressed in the developing
corneal mesenchyme, whereas Keratocan was also expressed at
lower levels in the conjunctival mesenchyme (Fig. 5D). In Pitx2-
tko littermates, the expression level in the corneal mesenchyme
was consistently lower than in control corneas and the pattern
was more diffuse (Fig. 5H). In this regard, the level and pattern
more closely resembled that of the conjunctival mesenchyme in
controls. To assess whether differentiation of the corneal mesen-
chyme was simply delayed, we assessed Keratocan expression in
older embryos. However, we observed the same complex expres-
sion pattern as in younger eyes with Keratocan expression pres-
ent in the mesenchyme of the cornea and conjunctiva (Fig. 6). As
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Fig. 2. Tamoxifen-induced ablation of PITX2 is highly efficient. Immu-
nohistochemistry was used on representative control and Pitx2-tko
mutant eyes to detect PITX2 expression at the indicated ages. All
timed pregnant females were injected with tamoxifen at e10.5 to ablate
the Pitx2 gene in prospective mutants. Only rare PITX2þ cells were
present in mutant mice.
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in the younger embryos, the expression pattern in the mesen-
chyme of mutant corneas more closely resembled that found in
the conjunctival mesenchyme. Together, these data show that fol-
lowing ablation of Pitx2, gene expression in the presumptive cor-
neal mesenchyme is altered at the developmental time point
(e12.5) that coincides with the first morphological evidence of
altered corneal development, and the protein and gene expression
patterns in the corneal mesenchyme of Pitx2-tko mutants resem-
ble that of the conjunctival mesenchyme.
Gene Expression in Pitx2-tko Corneal Ectoderm
Resembles That of Conjunctival Ectoderm
Signaling from the underlying mesenchyme dictates the fate of
the overlying surface ectoderm, including in the cornea (Pearton
et al., 2005). Therefore, based on the apparent fate switch in the
underlying mesenchyme from a corneal to a conjunctival charac-
ter, we examined markers whose expression patterns differentiate
between corneal and conjunctival ectoderm. However, at e13.5,
we found that in control embryos the transcription factors
FOXC2 and BARX2 are specifically expressed in the conjunctival
ectoderm but not in corneal ectoderm of control embryos (Fig.
7A,B). In Pitx2-tko littermates, FOXC2 and BARX2 are both
expressed throughout both the conjunctival and corneal ecto-
derm, which is consistent with at least a partial fate switch at this
timepoint (Fig. 7E,F). Further evidence for a fate switch within
the ectoderm was revealed by assessing the expression of the
intermediate filament proteins cytokeratin 4 (cK4), a specific
marker of conjunctival ectoderm, and cytokeratin 12 (cK12), a
specific marker of corneal ectoderm at e16.5 (Fig. 7C,D). In Pitx2-
tko eyes, expression of the cK4 expands to include cells within
both the conjunctival and corneal ectoderm (Fig. 7G), while
expression of the corneal marker cK12 is absent (Fig. 7H). There-
fore, the results of examining multiple markers expressed in each
embryonic tissue support the conclusion that following the loss
of Pitx2, corneal cell lineages are not specified correctly and that
both the mesenchyme and the ectoderm partially adopt conjunc-
tival fates.
PITX2 Is Required to Maintain Expression of Dkk2 in
Ocular Neural Crest
We have previously demonstrated that in neural crest during
early anterior segment morphogenesis, PITX2 is required for acti-
vation of Dkk2, which encodes an extracellular antagonist of
canonical Wnt signaling (Gage et al., 2008). Dkk2 expression is
activated in Pitx2-tko embryos prior to tamoxifen injection due
to the initial presence of PITX2 protein in these embryos (data
not shown). Since the previous experiments did not determine
whether PITX2 is also required for maintenance of Dkk2 expres-
sion, we examined Dkk2 expression in Pitx-tko eyes following
tamoxifen injection. We found that in mutant eyes, Dkk2 mRNA
D
E
V
E
L
O
P
M
E
N
T
A
L
 D
Y
N
A
M
IC
S Fig. 3. Altered corneal morphogenesis in Pitx2-tko eyes following ablation of Pitx2 by injection of tamoxifen at e10.5. H&E-stained coronal sec-
tions of control and mutant anterior segments at e11.5 (A,E), e12.5 (B,F), e14.5 (C,G), and e16.5 (D,H). Note that in the corneas of Pitx2-tko
mutants, there is an overabundance of mesenchyme beginning at 12.5, the endothelium and stroma layers do not form, the surface ectoderm is
modestly thickened, and the anterior chamber is absent. Ec, corneal ectoderm; M, corneal mesenchyme; L, lens; AC, anterior chamber; En, cor-
neal endothelium.
Fig. 4. PITX2 is required to establish angiogenic privilege in the devel-
oping cornea. Late gestation control and Pitx2-tko mutant corneas
immunostained to detect the presence of CD31 (A,C) and LYVE1 (B,D)
markers of the endothelium of blood vessels and lymphatic vessels,
respectively. C, corneal stroma; L, lens.
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is undetectable by e14.5 (Fig. 8C). As a consequence, canonical
Wnt signaling activity levels as measured by Axin2 expression
become elevated in Pitx2-tko eyes (Fig. 8D). Collectively, we con-
clude that functional PITX2 is required to both activate and main-
tain Dkk2 expression. The absence of DKK2 results in elevated
canonical Wnt signaling activity levels, providing a potential
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Fig. 5. Gene expression in the corneal mesenchyme is altered following ablation of Pitx2. Immunohistochemistry was used on control and Pitx2-
tko mutant corneas to detect expression of the FOXC2 (A,E) and PITX1 (B,F) transcription factors at e12.5 and e13.5, respectively. FOXC2 and
PITX1 protein expression expands from the conjunctiva into the cornea in mutant eyes. In situ hybridization was used to detect expression of the
Twist1 (C,G) and Keratocan (D,H) mRNA at e14.5. Twist1 mRNA is expressed in the mesenchyme of control but not Pitx2-tko mutant corneas.
Expression of Keratocan in mesenchyme of Pitx2tko corneas is reduced and more diffuse when compared to expression in mesenchyme of con-
trol corneas. CO, corneal mesenchyme; L, lens; Cn, conjunctival mesenchyme; EL, eyelid mesenchyme.
Fig. 6. Keratocan expression in e16.5 control and Pitx2-tko mutant eyes. In situ hybridization was used to detect Keratocan mRNA in e16.5
embryos. A’, B’: Magnified views of the central corneas from the eyes shown in A and B, respectively. C, corneal mesenchyme; Cn, conjunctival
mesenchyme.
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mechanism contributing to the observed morphological and gene
expression changes in the developing corneas of Pitx2-tko eyes.
Loss of Dkk2 Expression Accounts for a Subset of
Corneal Phenotypes in PItx2-tko Mice
We examined developing corneas of Dkk2-null mice and found
they exhibit morphological changes that are similar to those pres-
ent in Pitx-tko mutant corneas, including disruption of normal
organization within the stromal and endothelium layers of the
mesenchyme, and modest thickening of the overlying ectoderm
(Fig. 9A,E) (Gage et al., 2008). An important difference between
Pitx2-tko and Dkk2-/- mice, however, is the degree of corneal
angiogenesis. While ectopic CD31þ blood vessels are present in
the peripheral cornea of Dkk2-null eyes, in a position overlying
the ciliary body and where blood vessels are not found in wild
type controls (Fig. 9C,F), unlike what is observed in Pitx2-tko
eyes, these blood vessels do not extend into the central cornea
(Fig. 9B,F). Further, in the Dkk2-/- eyes, there is no evidence of
LYVE1þ lymphatic vessels in the cornea (Fig. 9D,H). Collectively,
these results suggest that corneal morphogenesis is disrupted but
the loss of angiogenic privilege in Pitx2-tko eyes is only partly
caused by decreased Dkk2 expression.
Next, we examined the corneal and conjunctival markers that
were altered in Pitx2-tko mice to determine whether they were
sensitive to loss of DKK2 and the associated changes in canonical
Wnt signaling activity levels. We began with the markers whose
expression patterns distinguish between differentiating cornea and
conjunctival mesenchyme. Interestingly, the expression patterns of
FOXC2, PITX1, Twist, and Keratocan were unaltered in Dkk2
mutant eyes relative to wild type controls (Fig. 10). From these
results, we infer that loss of DKK2 and the associated increase in
canonical Wnt signaling activity is unlikely to account for the
changes in expression of these genes present in PItx2-tko eyes. We
also examined the early conjunctival ectoderm markers, FOXC2
and BARX2, in control and mutant embryos at e14.5 (Fig. 11A,B).
In contrast to Pitx2-tko embryos, neither protein is expressed in
the corneal ectoderm of Dkk2-/- embryos at this same stage (Fig.
11E,F). Despite the lack of an effect on the early ectodermal
markers in the Dkk2-/- embryos, at later timepoints, expression of
the corneal marker keratin 12 is lost while expression of the con-
junctival marker keratin 4 is activated in the anatomical corneal
ectoderm of Dkk2-/- embryos. Collectively, these data suggest that
loss of DKK2 expression in the mesenchyme biases cells within the
overlying central ocular surface ectoderm toward conjunctival
rather than corneal fates. However, the expanded expression of
FOXC2 and BARX2 observed in Pitx2-tko embryos is unlikely to
contribute this fate switch since expression of these transcription
factors is unchanged in Dkk2 mice.
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the expression of FOXC2 at e13.5 (A,E), BARX2 at e13.5 (B,F), and keratin 4 (C,G) and keratin 12 (D,H) at e16.5. FOXC2, BARX2, and keratocan 4
are limited to the conjunctival ectoderm in control eyes but also expressed in the corneal ectoderm in Pitx2tko mutant eyes. Keratocan 12 is
expressed in the corneal ectoderm of control eyes but is absent from Pitx2-tko mutant eyes. Note: The FOXC2 signal in the lens is background
artifact due to the inherent stickiness of crystalline proteins. Co, corneal ectoderm; Cn, conjunctival ectoderm; L, lens.
Fig. 8. Expression of canonical Wnt pathway genes is altered during
corneal development in Pitx2-tko mice. In situ hybridization was used
to detect expression of the Dkk2 (A,C) and Axin2 (B,D) mRNA at e14.5.
Dkk2 expression is not maintained in the corneal mesenchyme while
Axin2 expression is elevated in both the corneal surface ectoderm and
underlying mesenchyme of Pitx2-tko eyes. E, corneal ectoderm; M,
corneal mesenchyme.
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Discussion
We have used a temporal knockout approach to reveal a require-
ment for the homeodomain transcription factor PITX2 in multiple
steps of corneal development. In the absence of PITX2, corneal
morphogenesis and the specification of cell fates within both the
surface ectoderm and mesenchymal primordia are disrupted.
PITX2 is also required to establish angiogenic privilege in the
developing cornea. Control of canonical Wnt signaling activity
levels as a result activation of the downstream target Dkk2 in the
underlying mesenchyme appears to be a key mechanism by
which PITX2 governs the correct specification of central ocular
surface ectoderm to a corneal epithelial fate. In contrast, the cor-
rect specification of the underlying mesenchymal cells to corneal
fates and establishing angiogenic privilege appear to be less sen-
sitive to loss of DKK2 activity. We identify several transcription
factors whose patterns in Pitx2 and Dkk2 mutants suggest that
they may be involved in cell fate specification and establishing
angiogenic privilege within the presumptive corneal mesenchyme
but are unlikely to play a role in cell fate specification within the
corneal ectoderm.
Normal Corneal Development Requires a Set of
Transcription Factors in the Neural Crest Mesenchyme
The current work extends our understanding of the transcrip-
tional code that is required for normal corneal development.
LMX1b encodes a homeodomain transcription factor that is
expressed in the ocular neural crest beginning early in eye devel-
opment and is associated with Nail-Patella Syndrome (Mcintosh
D
E
V
E
L
O
P
M
E
N
T
A
L
 D
Y
N
A
M
IC
S Fig. 9. Altered morphogenesis and relaxed angiogenic privilege in Dkk2 mutant mice. Control and Dkk2 mutant sections taken from e16.5
embryos stained with H&E (A,E). Comparable sections were immunostained to detect CD31 (B,F) or LYVE1 (D,H). CD31þ blood vessels were
ectopically located in the peripheral cornea adjacent to the ciliary body but did not extend towards the central cornea. C, G: Magnified images of
the boxed areas in B and F, respectively. C, cornea; CB, ciliary body; L, lens.
Fig. 10. Analysis of mesenchymal marker expression in control and Dkk2 mutant eyes. Immunohistochemistry was used on control and Dkk2 mutant
eyes at e12.5 to detect FOXC2 and PITX1 protein. In situ hybridization was used on embryos of the same genotypes at e14.5 to detect expression of
Twist1 and Keratocan mRNA. All markers were unchanged in Dkk2 mutant eyes relative to controls. Note: The FOXC2 signal in the lens is background
artifact due to the inherent stickiness of crystalline proteins. Co, corneal mesenchyme; Cn, conjunctival mesenchyme; EL, eyelid; L, lens.
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et al., 1998; Pressman et al., 2000; Vollrath et al., 1998).
Although human patients are not known to exhibit corneal
defects, Lmx1b knockout mice have defects in development of the
corneal stroma (Pressman et al., 2000). Heterozygous mutations
in FOXC1, encoding a forkhead transcription factor, are a second
cause of Axenfeld-Rieger Syndrome (Lehmann et al., 2000). Like
Pitx2, expression of Foxc1 in ocular neural crest mesenchyme
depends on retinoic acid signaling. Development of the corneal
stroma and endothelium is impaired in Foxc1 knockout mice
(Kidson et al., 1999). In addition, Foxc1 is required both to estab-
lish and maintain angiogenic privilege within the cornea (Seo
et al., 2012).
A striking feature of these three transcription factors is that
none are specifically limited to the corneal mesenchyme during
eye development. Indeed, all three are also co-expressed within
neural crest fated to form additional tissues such as the conjunc-
tival mesenchyme, the schlera, and structures within the iridocor-
neal angle. Therefore, although each is required, the ability to
specify corneal fates is not uniquely encoded by any one of these
three factors or in combination. This raises the possibility that
they cooperate together with one or more additional transcription
factors that are themselves specific to the corneal mesenchyme.
Alternatively, there may be other transcription factors whose
expression patterns encompass more than the cornea but the cor-
neal mesenchyme is the unique site where they are expressed
together with FOXC1, LMX1B, and PITX2.
Surface Ectoderm Is More Sensitive to Increases in
Canonical Wnt Signaling Activity Levels
Our data provide new insights in the relative sensitivities of the
surface ectoderm and underlying mesenchyme within the pre-
sumptive cornea to Dkk2 expression and the resulting suppres-
sion of canonical Wnt signaling activity levels. Ablation of Dkk2
is sufficient to cause an apparent switch from a corneal fate to a
conjunctival fate within the surface ectoderm, as evidenced by
the absence of the mature corneal marker, keratin 12, and the
presence of the mature conjunctival marker, keratin 4. In con-
trast, none of the mesenchymal markers examined were altered
in presumptive corneas of Dkk2 mutant mice and angiogenic
privilege was only partially affected as compared to Pitx2 mutant
corneas.
The difference in sensitivities to changes in canonical Wnt sig-
naling activity levels between the surface ectoderm and mesen-
chyme within the presumptive cornea mirrors the expression
patterns of both Wnt ligands and receptors. A minimum of four
genes encoding Frizzled receptor proteins are expressed within
the surface ectoderm of the developing cornea, meaning that this
layer is likely to be highly competent to respond to available Wnt
ligands (Liu et al., 2003). In contrast, only Frizzled 7 appears to
be expressed within the underlying mesenchyme during corneal
development, suggesting that these cells may be less responsive
to Wnt ligand (Liu et al., 2003). The surface ectoderm is also the
major source of available Wnt ligand within the region (Liu et al.,
2003). In contrast, the underlying neural crest mesenchyme is the
source of DKK2 (Gage et al., 2008). Collectively, these observa-
tions indicate that, during normal corneal development, paracrine
inhibition by DKK2 produced within the neural crest is required
to suppress the autocrine effect of Wnt ligand on the surface
ectoderm.
The mechanism(s) underlying the broader phenotype in the
absence of PITX2 relative to DKK2 are currently unclear and will
require more investigation. Recently, we have developed prelimi-
nary data suggesting that Dkk1 expression is also dramatically
reduced in the absence of PITX2 (Chen et al., preliminary results).
This suggests the possibility that canonical Wnt signaling activity
levels are more elevated in the Pitx2 mutants since the response
would be the sum of losing both DKK1 and DKK2. If true, the
higher activity levels may be sufficient to change fate choices by
the mesenchyme and alter establishment of angiogenic privilege
in a way that the presumably lesser activity levels of Dkk2
mutant corneas do not. An additional possibility that is not
mutually exclusive is that fate determination within the mesen-
chyme and establishing angiogenic privilege may be dependent
on input from other signaling pathways such as Nodal, FGF,
TGFb, and BMP, all of which are active within the developing
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anterior segment (Govindarajan et al., 2000; Saika et al., 2001;
Zhao et al., 2002).
Early Transcription Factor Markers Could Play Role in
Speciﬁcation of Corneal Mesenchyme or Establishing
Angiogenic Privilege
We have identified several markers whose expression patterns
within surface ectoderm and mesenchyme distinguish between
corneal and conjunctival fates early during the partitioning of
these two tissues. These markers represent important new tools
for analysis of fates, particularly at early stages of the process
when these patterns proteins are differentially expressed. As each
of these genes encodes a transcription factor, it raises the ques-
tion whether their regionalized expression patterns may be func-
tionally important for partitioning the surface ectoderm or
mesenchyme into corneal versus conjunctival fates. For example,
is exclusion of the normally conjunctival-specific expression of
FOXC2, PITX1, and BARX2 required for normal development of
the corneal ectoderm and mesenchyme, and for establishing
angiogenic privilege? The expansion of FOXC2 expression into
the cornea is particularly interesting with respect to establishing
angiogenic privilege since this transcription factor is well known
to promote angiogenesis under other normal and pathological
conditions, including cancer. Interestingly, alterations in func-
tional levels of the highly related family member, FOXC1 have
recently been shown to promote loss of angiogenic privilege in
the cornea (Seo et al., 2012).
Pitx2 Function in Later Developing Tissues and Mature
Structures
Schlemm’s canal and the trabecular meshwork within the irido-
corneal angle begin to differentiate towards the end of corneal
development and congenital defects in Pitx2-attributable
Axenfeld-Rieger patients suggest the likelihood that PITX2 is
required for development of these structures, in addition to the
cornea. Pitx2 is highly expressed within these structures during
eye development, lending support for functional significance
(data not shown). Long-term expression within the mature cor-
neal stroma and endothelium, Schlemm’s canal, and trabecular
meshwork also raises the possibility that PITX2 may play essen-
tial roles in maintenance of cell fate and renewal within these
structures. Application of the temporal knockout strategy
employed here at later stages of eye development and in mature
animals will now allow these important questions that were not
previously experimentally accessible to be addressed.
Experimental Procedures
Mouse Strains and Animal Husbandry
All experiments were conducted in accordance with the NIH
Guidelines for the Care and Use of Experimental Animals and all
procedures involving mice were approved by the University of
Michigan Committee on Use and Care of Animals. Generation of
the Pitx2nullþ, Pitx2flox, UBC-CreERT2, and Dkk2null mouse strains
has been described previously (Gage et al., 1999; Gruber et al.,
2007; Li et al., 2005; Ruzankina et al., 2007). Mice were mated to
generate timed pregnancies. The relevant crosses are UBC-
CreERT2; Pitx21/null X Pitx2flox/flox; R26R/R26R and Dkk21/null
x Dkk21/null. If indicated, a single intraperitoneal injection of
tamoxifen (Sigma, St. Louis, MO) suspended in corn oil at a dose
of 100 mg per gram body weight was administered to the preg-
nant dam at noon on the day noted. The resulting embryos were
genotyped for Cre or Pitx2 using PCR-based methods (Evans and
Gage, 2005a; Suh et al., 2002), and processed for histology as
previously described (Evans and Gage, 2005a).
Embryo Processing and Histology
All embryos were fixed in 4% paraformaldehyde diluted in PBS,
washed in PBS, dehydrated though graded alcohols, and proc-
essed into Paraplast Plus (McCormick Scientific; St. Louis, MO)
for paraffin sectioning. Mounted paraffin sections for morpho-
logical analysis were dewaxed, rehydrated, and stained with
hematoxylin and eosin.
Immunostaining and RNA In Situ Hybridization
Paraffin sections were immunostained as previously described
(Evans and Gage, 2005a). Primary antibodies against PITX2 (gift
from T. Hjalt, Lund University), CD31 (BD Pharmingen, Franklin
Lakes, NJ), LYVE-1 (Abcam, Cambridge, MA), FOXC2 (Abcam),
PITX1 (gift from Jacques Drouin, International Cancer Research
Center of Montreal), BARX2 (Santa Cruz Biotechnology, Santa
Cruz, CA), keratin 4 (Abcam), and keratin 12 (gift from Winston
Kao, University of Cincinnati) were used. Digoxigenin-labeled
riboprobes against Pitx2, Dkk2 (gift from Gary Hammer, Univer-
sity of Michigan), Axin2 (gift from Sally Camper, University of
Michigan), Twist1, and Keratocan (gift from Winston Kao, Uni-
versity of Cincinnati) were generated and used to stain paraffin
sections as previously described (Cushman et al., 2001; Martin
et al., 2002).
Acknowledgments
The authors thank Millie Mo and Mie Kasanuki for technical assis-
tance. The authors also thank Lisheng Chen and Peter Hitchcock
for helpful discussions and for comments on the manuscript. This
work was supported by the National Eye Institute of the National
Institutes of Health (EY007003, EY014126) to P.J.G.
References
Asai-Coakwell M, Backhouse C, Casey RJ, Gage PJ, Lehmann OJ.
2006. Reduced human and murine corneal thickness in an
Axenfeld-Rieger syndrome subtype. Invest Ophthalmol Vis Sci
47:4905–4909.
Chow RL, Lang RA. 2001. Early eye development in vertebrates.
Annu Rev Cell Dev Biol 17:255–296.
Cushman LJ, Watkins-Chow DE, Brinkmeier ML, Raetzman LT,
Radak AL, Lloyd RV, Camper SA. 2001. Persistent Prop1 expres-
sion delays gonadotrope differentiation and enhances pituitary
tumor susceptibility. Hum Mol Genet 10:1141–1153.
Cvekl A, Tamm ER. 2004. Anterior eye development and ocular
mesenchyme: new insights from mouse models and human dis-
eases. Bioessays 26:374–386.
Evans AL, Gage PJ. 2005a. Expression of the homeobox gene
Pitx2 in neural crest is required for optic stalk and ocular anterior
segment development. Hum Mol Genet 14:3347–3359.
Evans AL, Gage PJ. 2005b. Expression of the homeobox gene
Pitx2 in neural crest is required for optic stalk and ocular anterior
segment development. Human Mol Genet 14:3347–3359.
Gage PJ, Suh H, Camper SA. 1999. Dosage requirement of Pitx2
for development of multiple organs. Development 126:
4643–4651.
D
E
V
E
L
O
P
M
E
N
T
A
L
 D
Y
N
A
M
IC
S
CELL FATE AND ANGIOGENIC PRIVILEGE IN THE CORNEA 1399
Gage PJ, Rhoades W, Prucka SK, Hjalt TA. 2005. Fate maps of
neural crest and mesoderm in the mammalian eye. Invest Oph-
thalmol Vis Sci 46:4200–4208.
Gage PJ, Qian M, Wu D, Rosenberg KI. 2008. The canonical Wnt
signaling antagonist DKK2 is an essential effector of PITX2 func-
tion during normal eye development. Dev Biol 317:310–324.
Govindarajan V, Ito M, Makarenkova HP, Lang RA, Overbeek PA.
2000. Endogenous and ectopic gland induction by FGF-10. Dev
Biol 225:188–200.
Gruber M, Hu CJ, Johnson RS, Brown EJ, Keith B, Simon MC.
2007. Acute postnatal ablation of Hif-2alpha results in anemia.
Proc Natl Acad Sci USA 104:2301–2306.
Kidson SH, Kume T, Deng K, Winfrey V, Hogan BL. 1999. The fork-
head/winged-helix gene, Mf1, is necessary for the normal devel-
opment of the cornea and formation of the anterior chamber in
the mouse eye. Dev Biol 211:306–322.
Le Douarin NM. 1980. Migration and differentiation of neural crest
cells. In: Moscona A, Monroy A, editors. Current topics in devel-
opment, part II. New York: Academic Press.
Le Lievre CS, Le Douarin NM. 1975. Mesenchymal derivatives of
the neural crest: analysis of chimaeric quail and chick embryos.
J Embryol Exp Morphol 34:125–154.
Lehmann OJ, Ebenezer ND, Jordan T, Fox M, Ocaka L, Payne A,
Leroy BP, Clark BJ, Hitchings RA, Povey S, Khaw PT,
Bhattacharya SS. 2000. Chromosomal duplication involving the
forkhead transcription factor gene FOXC1 causes iris hypoplasia
and glaucoma. Am J Hum Genet 67:1129–1135.
Li X, Liu P, Liu W, Maye P, Zhang J, Zhang Y, Hurley M, Guo C,
Boskey A, Sun L, Harris SE, Rowe DW, Ke HZ, Wu D. 2005.
Dkk2 has a role in terminal osteoblast differentiation and mineral-
ized matrix formation. Nat Genet 37:945–952.
Liu CY, Shiraishi A, Kao CW, Converse RL, Funderburgh JL,
Corpuz LM, Conrad GW, Kao WW. 1998. The cloning of mouse
keratocan cDNA and genomic DNA and the characterization of
its expression during eye development. J Biol Chem 273:22584–
22588.
Liu H, Mohamed O, Dufort D, Wallace VA. 2003. Characterization
of Wnt signaling components and activation of the Wnt canonical
pathway in the murine retina. Dev Dyn 227:323–334.
Martin DM, Skidmore JM, Fox SE, Gage PJ, Camper SA. 2002.
Pitx2 distinguishes subtypes of terminally differentiated neurons
in the developing mouse neuroepithelium. Dev Biol 252:84–99.
Matt N, Dupe V, Garnier JM, Dennefeld C, Chambon P, Mark M,
Ghyselinck NB. 2005. Retinoic acid-dependent eye morphogene-
sis is orchestrated by neural crest cells. Development 132:
4789–4800.
Mcintosh I, Dreyer SD, Clough MV, Dunston JA, Eyaid W, Roig
CM, Montgomery T, Ala-Mello S, Kaitila I, Winterpacht A, Zabel
B, Frydman M, Cole WG, Francomano CA, Lee B. 1998. Muta-
tion analysis of LMX1B gene in nail-patella syndrome patients.
Am J Hum Genet 63:1651–1658.
Molotkov A, Molotkova N, Duester G. 2006. Retinoic acid guides
eye morphogenetic movements via paracrine signaling but is
unnecessary for retinal dorsoventral patterning. Development
133:1901–1910.
Pearton DJ, Yang Y, Dhouailly D. 2005. Transdifferentiation of cor-
neal epithelium into epidermis occurs by means of a multistep
process triggered by dermal developmental signals. Proc Natl
Acad Sci USA 102:3714–3719.
Pressman CL, Chen H, Johnson RL. 2000. LMX1B, a LIM homeo-
domain class transcription factor, is necessary for normal devel-
opment of multiple tissues in the anterior segment of the murine
eye. Genesis 26:15–25.
Ruzankina Y, Pinzon-Guzman C, Asare A, Ong T, Pontano L,
Cotsarelis G, Zediak VP, Velez M, Bhandoola A, Brown EJ. 2007.
Deletion of the developmentally essential gene ATR in adult mice
leads to age-related phenotypes and stem cell loss. Cell Stem
Cell 1:113–126.
Saika S, Liu CY, Azhar M, Sanford LP, Doetschman T, Gendron RL,
Kao CW, Kao WW. 2001. TGFbeta2 in corneal morphogenesis
during mouse embryonic development. Dev Biol 240:419–432.
Semina EV, Reiter R, Leysens NJ, Alward WL, Small KW, Datson
NA, Siegel-Bartelt J, Bierke-Nelson D, Bitoun P, Zabel BU, Carey
JC, Murray JC. 1996. Cloning and characterization of a novel
bicoid-related homeobox transcription factor gene, RIEG,
involved in Rieger syndrome. Nat Genet 14:392–399.
Seo S, Singh HP, Lacal PM, Sasman A, Fatima A, Liu T, Schultz
KM, Losordo DW, Lehmann OJ, Kume T. 2012. Forkhead box
transcription factor FoxC1 preserves corneal transparency by
regulating vascular growth. Proc Natl Acad Sci USA 109:2015–
2020.
Suh H, Gage PJ, Drouin J, Camper SA. 2002. Pitx2 is required at
multiple stages of pituitary organogenesis: pituitary primordium
formation and cell specification. Development 129:329–337.
Thut CJ, Rountree RB, Hwa M, Kingsley DM. 2001. A large-scale
in situ screen provides molecular evidence for the induction of
eye anterior segment structures by the developing lens. Dev Biol
231:63–76.
Vollrath D, Jaramillo-Babb VL, Clough MV, Mcintosh I, Scott KM,
Lichter PR, Richards JE. 1998. Loss-of-function mutations in the
LIM-homeodomain gene, LMX1B, in nail-patella syndrome. Hum
Mol Genet 7:1091–1098.
Zacharias AL, Lewandoski M, Rudnicki MA, Gage PJ. 2011. Pitx2
is an upstream activator of extraocular myogenesis and survival.
Dev Biol 349:395–405.
Zhao S, Chen Q, Hung FC, Overbeek PA. 2002. BMP signaling is
required for development of the ciliary body. Development 129:
4435–4442.
D
E
V
E
L
O
P
M
E
N
T
A
L
 D
Y
N
A
M
IC
S
1400 GAGE ET AL.
